Gut |
Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy |
oct. 15 |
3 ♥ |
Endoscopie/Imagerie, Cancer colorectal (CCR), Cancers autres, Génétique |
Hepatology |
Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial. |
juin. 16 |
5 ♥ |
Endoscopie/Imagerie |
New England Journal of Medicine (NEJM) |
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection. |
Jan. 18 |
4 ♥ |
Foie |
New England Journal of Medicine (NEJM) |
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. |
aoû. 16 |
3 ♥ |
Foie |
New England Journal of Medicine (NEJM) |
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. |
Jan. 17 |
3 ♥ |
Cancers autres |
New England Journal of Medicine (NEJM) |
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component |
sep. 15 |
4 ♥ |
Foie |
New England Journal of Medicine (NEJM) |
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
New England Journal of Medicine (NEJM) |
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma. |
juil. 18 |
2 ♥ |
Foie |
New England Journal of Medicine (NEJM) |
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients. |
avr. 19 |
4 ♥ |
Foie |
Journal of clinical oncology (JCO) |
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database. |
fév. 18 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. |
mar. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
National Trends in Nonoperative Management of Rectal Adenocarcinoma. |
juin. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study. |
mar. 19 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. |
juin. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. |
mai. 19 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. |
fév. 19 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2. |
Jan. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. |
avr. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110). |
Jan. 19 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial |
Jan. 16 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Popstantot |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
mar. 18 |
4 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. |
Jan. 16 |
4 ♥ |
Cancer colorectal (CCR) |